Assessment of somatostatin receptor expression in predicting results of PRRT (peptide receptor radionuclide therapy) in disseminated neuroendocrine tumours (NET)

被引：0
|
作者：
Hubalewska-Dydejayk, Alicja B. [1 ]
Sowa-Staszczak, Anna [1 ]
Trofimiuk, Malgorzata [1 ]
Stefanska, Agnieszka [1 ]
Wierzchowski, Wojciech [2 ]
Kunikowska, Jolanta [3 ]
Pach, Dorota [1 ]
Tomaszewska, Romana [2 ]
机构：
[1] Jagiellonian Univ, Coll Med, Nucl Med Unit, Dept Endocrinol, Krakow, Poland
[2] Jagiellonian Univ, Coll Med, Dept Pathol, Krakow, Poland
[3] Med Univ, Dept Nucl Med, Warsaw, Poland
来源：
ENDOCRINE JOURNAL | 2010年 / 57卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S443 / S443
页数：1
相关论文
共 50 条
  • [41] Somatostatin receptor radionuclide therapy in neuroendocrine tumors
    Haider, Mintallah
    Das, Satya
    Al-Toubah, Taymeyah
    Pelle, Eleonora
    El-Haddad, Ghassan
    Strosberg, Jonathan
    ENDOCRINE-RELATED CANCER, 2021, 28 (03) : R81 - R93
  • [42] Comparative retrospective study of peptide receptor radionuclide therapy (PRRT) with Y-90-DOTATOC and Y-90-DOTATATE in neuroendocrine tumours (NET)
    Marx, M.
    Plagge, H.
    Winkler, C.
    Zhao, Y.
    Luetzen, U.
    Zuhayra, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2015, 42 : S846 - S847
  • [43] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
    Del Prete, Michela
    Buteau, Francois-Alexandre
    Arsenault, Frederic
    Saighi, Nassim
    Bouchard, Louis-Olivier
    Beaulieu, Alexis
    Beauregard, Jean-Mathieu
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (03) : 728 - 742
  • [44] Personalized 177Lu-octreotate peptide receptor radionuclide therapy of neuroendocrine tumours: initial results from the P-PRRT trial
    Michela Del Prete
    François-Alexandre Buteau
    Frédéric Arsenault
    Nassim Saighi
    Louis-Olivier Bouchard
    Alexis Beaulieu
    Jean-Mathieu Beauregard
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 728 - 742
  • [45] Peptide Receptor Radionuclide Therapy (PRRT) as neoadjuvant therapy in neuroendocrine tumors - one center experience
    Opalinska, M.
    Sowa-Staszczak, A.
    Grochowska, A.
    Zwinczewska, H.
    Hubalewska-Dydejczyk, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2021, 48 (SUPPL 1) : S334 - S334
  • [46] Peptide Receptor Radionuclide Therapy (PRRT) of Neuroendocrine Tumor Patients with Carcinoid Heart Disease
    Prasad, V
    Secknus, M. A.
    Hoersch, D.
    Kuntze, T.
    Zachert, C.
    Baum, R. P.
    NEUROENDOCRINOLOGY, 2009, 90 (01) : 133 - 133
  • [47] Clonal Hematopoiesis in Patients with Neuroendocrine Tumors Receiving Peptide Receptor Radionuclide Therapy (PRRT)
    Singh, Abhay
    Gravina, Matthew
    Tajammal, Rutaba
    Nowak, Annmarie
    Iyer, Renuka
    Faber, Mark G.
    Yan, LunBiao
    Hassane, Duane C.
    Guzman, Monica L.
    Mencia-Trinchant, Nuria
    Wang, Eunice S.
    Thota, Swapna
    BLOOD, 2020, 136
  • [48] Peptide receptor radionuclide therapy (PRRT) of neuroendocrine tumors: current state and future perspectives
    Baum, Richard P.
    Puranik, Ameya D.
    Kulkarni, Harshad R.
    INTERNATIONAL JOURNAL OF ENDOCRINE ONCOLOGY, 2015, 2 (02) : 151 - 158
  • [49] Circulating Neuroendocrine Tumor Gene Expression for Monitoring Peptide Receptor Radionuclide (PRRT) Efficacy
    Bodei, L.
    Kidd, M.
    Van der Zwan, W.
    Singh, A.
    Severi, S.
    Drozdov, I
    Cwikla, J.
    Kolasinska-Cwikla, A.
    Baum, R. P.
    Paganelli, G.
    Krenning, E.
    Modlin, I
    NEUROENDOCRINOLOGY, 2019, 108 : 113 - 113
  • [50] Toxicity identification and evaluation of peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors (NETs)
    Duan, Heying
    Girod, Bradley
    Ninatti, Gaia
    Ferri, Valentina
    Kunz, Pamela
    Fisher, George
    Moradi, Farshad
    Davidzon, Guido
    Franc, Benjamin
    Iagaru, Andrei
    Aparici, Carina Mari
    JOURNAL OF NUCLEAR MEDICINE, 2020, 61
12345